Through our outstanding research capabilities and rigorous quality system, CD Formulation is dedicated to providing comprehensive toxicology research services for the development of nucleic acid drugs, ensuring their safety and stability to support the global biopharmaceutical industry's growth. Our team is comprised of experienced scientists and certified toxicologists capable of meeting diverse client needs, thereby driving the success of each research project.
As molecular biology technologies advance swiftly, nucleic acid drug R&D has emerged as a central focus in biopharma. The success of mRNA vaccines underscores the significant potential of these drugs. Nevertheless, unlike traditional small-molecule and protein therapies, nucleic acid drugs encounter distinct safety challenges. These include potential immune reactions, adverse metabolic pathways, and possible genotoxicity. Therefore, highly specialized toxicological studies are needed to comprehensively assess and understand these risks, supporting subsequent drug development decisions.
With strict international standard certifications and advanced experimental facilities, CD Formulation is the ideal choice for general toxicology research services. By consistently adhering to high-standard quality management systems, we ensure the accuracy and reliability of our research, enabling us to flexibly handle various complex toxicological challenges, providing precise scientific support and innovative solutions to our clients.
Items | Descriptions |
---|---|
Acute Toxicity Tests | Our acute toxicity tests are designed to assess the short-term toxicity potential of nucleic acid drugs, observing their effects on organisms following a single dose to provide foundational data support for subsequent research. |
Toxicokinetics Studies | Through precise analytical techniques, our research team can track the absorption, distribution, metabolism, and excretion processes of nucleic acid drugs in organisms, thereby comprehensively assessing their bioavailability and metabolic pathways. |
Repeated Dose Toxicity Tests | These tests help determine the long-term safety of nucleic acid drugs by designing reasonable dose escalation schemes to evaluate the systemic effects of long-term administration on animals. |
Designing personalized toxicological research plans based on each nucleic acid drug's characteristics and specific client requirements to ensure the precision and effectiveness of results.
CD Formulation emphasizes ensuring all research data's accuracy and completeness, adhering to globally recognized standards to maintain a high level of quality. During data collection, storage, and analysis, strict compliance measures are implemented to guarantee data reliability and consistency, supporting efficient project submissions and regulatory reviews.
We adopt a three-tier quality management system to ensure that every step in the research process meets the highest international standards while maintaining flexibility to adapt to new scientific challenges.
Fig.1 Flow chart of general toxicology studies for nucleic acid drugs. (CD Formulation)
Through initial communication, clearly understanding the client's research goals and specific requirements to plan and design the most suitable research plan.
In internationally certified facilities, experienced scientific teams conduct toxicological experiments to ensure the rigor and scientific nature of each test phase.
Utilizing advanced data analysis tools to generate comprehensive toxicology reports, with professional toxicologists providing in-depth results interpretation and recommendations.
We provide clients with clear and detailed reports and offer professional advice on research findings to aid clients in making optimal decisions.
Technology: Toxicology Research Platform for Drug Development and Utilization
Journal: Drug discovery today
IF: 6.5
Published: 2014
Results:
To tackle toxicity-related issues, the pharmaceutical industry employs various strategies. In Part I, the authors explored their ‘integrated toxicology' approach, which supports early decision-making and guides discovery teams by identifying potential failures. In Part II, they detail their compound testing strategies focusing on cardiovascular safety, hepatotoxicity, genotoxicity, immunotoxicity, and exploratory in vivo toxicity. They summarize the in vitro, ex vivo, and in vivo assays and models used to assess safety risks and refine compounds, emphasizing their predictive power and decision-making impact.
Fig.2 Timing of exploratory toxicology assays during the drug discovery project phases. (Hornberg J J, et al., 2014)
CD Formulation is committed to conducting toxicology research to the highest standards, offering first-class service and innovative solutions to help clients achieve breakthrough progress in nucleic acid drug development. Our goal is to promote the development of new drugs by scientifically evaluating and rigorously researching, ensuring their safety and efficacy are precisely assessed and guaranteed at every stage of research. Contact us, and we will tailor solutions for your project.
References